Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q4)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.13%4.03M | -84.09%983K | -24.64%23.61M | -13.27%4.48M | -72.73%2.25M | -7.70%10.7M | -2.09%6.18M | 11.40%31.33M | -51.41%5.17M | 101.07%8.26M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 839.12%8.07M | -62.63%4.74M | -32.74%37.29M | -94.08%859K | -60.80%6.01M | 12.69%17.29M | 24.23%12.68M | 143.94%55.44M | 380.72%14.51M | 77.15%15.32M |
| Other operating expenses | -18.18%8.07M | -62.93%4.74M | -16.51%46.29M | -32.03%9.86M | -58.64%6.36M | 12.69%17.29M | 25.01%12.79M | 846.65%55.44M | 165.28%14.51M | 76.09%15.36M |
| Total other operating income | ---- | ---- | --9M | --9M | 695.45%350K | ---- | 466.67%102K | --0 | ---- | -42.86%44K |
| Operating profit | -211.42%-4.04M | 42.24%-3.76M | 43.27%-13.67M | 138.82%3.62M | 46.84%-3.75M | -75.77%-6.59M | -66.84%-6.51M | -31.96%-24.1M | -18.75%-9.34M | -55.50%-7.06M |
| Net non-operating interest income (expenses) | -311.32%-436K | -13.16%-129K | 1.46%-471K | 0.93%-106K | -33.04%-149K | -8.50%-166K | 1.72%-114K | -35.41%-478K | -101.89%-107K | -12.00%-112K |
| Non-operating interest income | ---- | ---- | 720.00%82K | --18K | ---- | ---- | ---- | -93.46%10K | ---- | ---- |
| Non-operating interest expense | 251.61%436K | 13.16%129K | 13.32%553K | 15.89%124K | 33.04%149K | 8.50%166K | -1.72%114K | 0.00%488K | -43.09%107K | 12.00%112K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0.00%327K | 0 | 327K | |||||||
| Income from associates and other participating interests | 1,887.50%159K | -102K | -57K | 8K | -65K | 0 | 0 | 0 | ||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | 4,942.86%353K | 25K | 615.38%93K | -95.51%7K | -81.20%25K | -82.67%13K | 156K | |||
| Income before tax | -212.14%-3.96M | 40.13%-3.96M | 43.15%-13.78M | 138.04%3.53M | 44.69%-3.97M | -78.58%-6.73M | -64.86%-6.62M | -30.72%-24.24M | -18.46%-9.29M | -54.56%-7.17M |
| Income tax | 0 | 0 | -242.16%-917K | 0 | 0 | 99.42%-1K | -1,353.97%-916K | -2,877.78%-268K | -30.32%262K | -309.72%-295K |
| Net income | -212.14%-3.96M | 30.51%-3.96M | 46.34%-12.86M | 137.00%3.53M | 42.31%-3.97M | -87.10%-6.73M | -44.31%-5.7M | -29.33%-23.97M | -16.22%-9.55M | -50.54%-6.88M |
| Net income continuous operations | -212.14%-3.96M | 30.51%-3.96M | 46.34%-12.86M | 137.00%3.53M | 42.31%-3.97M | -87.10%-6.73M | -44.31%-5.7M | -29.33%-23.97M | -16.22%-9.55M | -50.54%-6.88M |
| Noncontrolling interests | -5,362.50%-437K | -106.84%-13K | 60.71%-222K | 99.04%-8K | -126.74%-77K | -408.49%-327K | 247.29%190K | 38.92%-565K | -468.49%-830K | 152.65%288K |
| Net income attributable to the company | -199.55%-3.53M | 32.97%-3.95M | 45.99%-12.64M | 140.61%3.54M | 45.71%-3.89M | -72.91%-6.4M | -54.15%-5.89M | -32.92%-23.41M | -8.04%-8.72M | -78.18%-7.16M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -199.55%-3.53M | 32.97%-3.95M | 45.99%-12.64M | 140.61%3.54M | 45.71%-3.89M | -72.91%-6.4M | -54.15%-5.89M | -32.92%-23.41M | -8.04%-8.72M | -78.18%-7.16M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -200.00%-0.0047 | 36.14%-0.0053 | 48.63%-0.0169 | 138.52%0.0047 | 49.51%-0.0052 | -61.11%-0.0087 | -50.91%-0.0083 | -26.05%-0.0329 | -1.67%-0.0122 | -71.67%-0.0103 |
| Diluted earnings per share | -0.0047 | 36.14%-0.0053 | 48.63%-0.0169 | 0 | 49.51%-0.0052 | -61.11%-0.0087 | -50.91%-0.0083 | -26.05%-0.0329 | -1.67%-0.0122 | -71.67%-0.0103 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.